You are here

  • Home
  • Archive
  • Volume 75, Issue Suppl 2
  • FRI0236 Safety, Pharmacokinetics and Efficacy of E6011, An Anti-Fractalkine Monoclonal Antibody, in A First-in-Patient Phase 1/2 Study in Rheumatoid Arthritis

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Rheumatoid arthritis - other biologic treatment
FRI0236 Safety, Pharmacokinetics and Efficacy of E6011, An Anti-Fractalkine Monoclonal Antibody, in A First-in-Patient Phase 1/2 Study in Rheumatoid Arthritis

 

Online download statistics by month:

Online download statistics by month: July 2016 to March 2024

AbstractFullPdf
Jul 2016300
Aug 2016502
Sep 20161004
Oct 2016402
Nov 2016602
Dec 20161200
Jan 2017901
Feb 20173300
Mar 20172304
Apr 2017800
May 20171103
Jun 20171101
Jul 20173901
Aug 20172401
Sep 20173203
Oct 20171801
Nov 20171600
Dec 20171000
Jan 20182200
Feb 20182600
Mar 20181600
Apr 20181200
May 20181401
Jun 2018800
Jul 20181200
Aug 2018800
Sep 20181200
Oct 2018801
Nov 20181200
Jan 2019600
Feb 2019601
Mar 2019400
Apr 2019700
May 2019403
Jul 2019200
Aug 2019600
Oct 2019002
Nov 2019200
Dec 2019400
Jan 2020900
Feb 2020400
Apr 2020200
Jun 2020400
Jul 2020701
Aug 2020400
Sep 20201600
Nov 2020400
Dec 2020800
Jan 2021200
May 2021100
Jul 2021100
Oct 2021200
Nov 2021700
Dec 20211000
Jan 2022200
Feb 2022400
Mar 2022800
Apr 2022800
May 2022800
Jun 2022400
Jul 2022700
Aug 20221200
Sep 2022800
Oct 2022200
Nov 2022700
Dec 20221600
Jan 20231700
Feb 2023600
Mar 2023600
May 2023200
Jun 20231001
Jul 2023600
Aug 2023200
Sep 2023800
Oct 2023600
Nov 2023400
Dec 2023800
Jan 2024200
Feb 2024200
Mar 2024601
Total717036